Stock comparison
Guardian Pharmacy Services
Eli Lilly
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GRDN
Guardian Pharmacy Services
Market cap
$2.44B
Sector
Healthcare
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GRDN | LLY | Winner |
|---|---|---|---|
| Warren Buffett | 54C | 72B | LLY |
| Benjamin Graham | 62D | 86A | LLY |
| Philip Fisher | 57C | 86A | LLY |
| Peter Lynch | 60C | 74B | LLY |
| Joel Greenblatt | 61C | 78C | LLY |
| Charlie Munger | 47D | 85A | LLY |
| Terry Smith | 52C | 77C | LLY |
Side-by-side metrics
| Metric | GRDN | LLY |
|---|---|---|
| Market cap | $2.44B | $1T |
| P/E (TTM) | 42.7x | 36.6x |
| EV/EBIT | 30.8x | 34.1x |
| ROIC (TTM) | 20.71% | 32.06% |
| Gross margin | 20.93% | 83.51% |
| Net margin | 3.64% | 34.98% |
| Revenue CAGR 5y | 16.29% | 23.17% |
| EPS CAGR 5y | 30.79% | 40.81% |
| Debt / Equity | 0.2x | 1.4x |
| Dividend yield | 0.0% | 0.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GRDN leads on
- Debt / Equity0.2xvs 1.4x+88%
- EV/EBIT30.8xvs 34.1x+10%
LLY leads on
- Dividend yield0.62%vs 0.0%+100%
- Market cap$1Tvs $2.44B+100%
- Net margin34.98%vs 3.64%+90%
- Gross margin83.51%vs 20.93%+75%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.